Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

Bruguiera gymnorhiza leaf extracts show potential for developing anti-inflammatory drugs.

Clascoterone 1% cream is a promising new treatment for acne.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Medications for PCOS don't seem to raise heart disease risk.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Finasteride causes harmful organ changes in female mice.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Birth control pills can cause skin issues but may help with acne and hirsutism, and choosing the right type can minimize side effects.

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Exposure to certain chemicals in food and containers may increase the risk of early breast development in young girls.

Many males in Jordan misuse oral contraceptive pills for hair growth, muscle gain, and acne treatment.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.